To raise profile of a spin-out company with investors, clinical influencers, healthcare commissioners and potential partners and clients.
Congenica was a spin-out from the Wellcome Trust Sanger Institute. It gained funding to convert its prototype product from a research project to a robust solution for the Genomics England 100,000 Genomes project. Holdsworth Associates was asked to raise its profile following the initial funding.
Our campaign was so successful – generating significant national interest and international broadcast coverage – that we were invited to support the company with a sustained PR campaign to support its growth. With our support, the company grew from 5 to 50 people and gained international exposure.
Through a creative approach to PR over 36 months we generated 37 press releases and 12 feature articles, including a review in the Journal of Precision Medicine that we researched and drafted. This resulted in coverage in over 130 publications – including the client’s Tier One targets – both in print and online.
We supported this media relations strategy through interviews with senior NHS clinicians talking about the potential of the technology and the impact of Congenica’s solution.
We also sourced patients through patient support groups and physicians that were prepared to talk about their experiences, which created human interest stories.
Coverage in publications including:
National: BBC Health News, BBC Radio 4, ITV News, Financial Times, Metro, The Guardian, The Sunday Telegraph, The Sunday Times, Fortune
Science and technology: Nature, The Journal of Precision Medicine, Laboratory News, Personalised Medicine, Engineering and Technology Magazine
Regional: BBC Look East, BBC North West Tonight, BBC Radio Cambridgeshire, Eastern Daily Press
I want to thank you for helping us over the last few years in building our company’s profile. You did a really good job, and I will certainly recommend you to my friends and colleagues setting up newcos.